Intravenous GPIIb/IIIa Inhibitor for Secondary Prevention of Shunt Thrombosis in a Pediatric Patient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 26046909.
- Also identified by DOI 10.1016/j.athoracsur.2015.02.103.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thrombosis occurs after aortopulmonary shunting in children despite the use of heparin and oral antiplatelet agents. We describe the use of an intravenous antiplatelet agent for secondary prevention of shunt thrombosis without adverse events. Platelet mapping was used to monitor the effects and demonstrated the rapid onset of platelet inhibition.
Medical subject headings
- Aorta, Thoracic
- Platelet Glycoprotein GPIIb-IIIa Complex
- Pulmonary Artery
- Secondary Prevention
- Thrombosis